Postmenopausal hormone therapy and quality of life
暂无分享,去创建一个
D. Grové | D. Hall | D. Hall | A.J. Smith | A. Smith
[1] F. Naftolin,et al. Guidelines for the hormone treatment of women in the menopausal transition and beyond. , 2005, Climacteric : the journal of the International Menopause Society.
[2] K. Maki,et al. A Multicenter, Open-Label Study to Evaluate Satisfaction and Menopausal Quality of Life in Women Using Transdermal Estradiol/Norethindrone Acetate Therapy for the Management of Menopausal Signs and Symptoms , 2005, Gynecologic and Obstetric Investigation.
[3] C. Acquadro,et al. Literature review of instruments to assess health-related quality of life during and after menopause , 2005, Quality of Life Research.
[4] D. Grové,et al. Current patient perceptions on the menopause: a South African perspective , 2005, Climacteric : the journal of the International Menopause Society.
[5] H. Burger,et al. Guidelines for hormone treatment of women in the menopausal transition and beyondPosition Statement by the Executive Committee of the International Menopause Society (Revised October 15, 2004) , 2004, Climacteric : the journal of the International Menopause Society.
[6] M. Hammar,et al. Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. , 2004, Maturitas.
[7] W. Utian,et al. Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale , 2004, Menopause.
[8] T. B. Üstün,et al. Global burden of depressive disorders in the year 2000 , 2004, British Journal of Psychiatry.
[9] Nicola J Cooper,et al. Benefits and harms associated with hormone replacement therapy: clinical decision analysis , 2004, BMJ : British Medical Journal.
[10] J. Blümel,et al. Patients' and clinicians' attitudes after the Women's Health Initiative study , 2004, Menopause.
[11] Jan Scott,et al. Global burden of depression: The intersection of culture and medicine , 2003, British Journal of Psychiatry.
[12] J. Manson,et al. Effects of estrogen plus progestin on health-related quality of life. , 2003, The New England journal of medicine.
[13] A. Strothmann,et al. Hormone therapy: the European women's perspective , 2003, Climacteric : the journal of the International Menopause Society.
[14] M. Schluchter,et al. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause , 2002, Menopause.
[15] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[16] E. Vittinghoff,et al. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. , 2002, JAMA.
[17] E. Alder. The Blatt-Kupperman menopausal index: a critique. , 1998, Maturitas.
[18] J. Greene. Constructing a standard climacteric scale. , 1998, Maturitas.
[19] Earl R. Babbie,et al. The practice of social research , 1969 .
[20] P. Kenemans,et al. Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life. , 2004, Drugs.